{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Juglans mandshurica var. cordiformis", "Juglans mandshurica var. sachalinensis", "juglone", "naphthoquinone", "transthyretin protein (TTR)", "transthyretin-related amyloidosis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30704121", "DateCompleted": {"Year": "2019", "Month": "05", "Day": "20"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "30"}], "Language": ["eng"], "ELocationID": ["500", "10.3390/molecules24030500"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "3", "PubDate": {"Year": "2019", "Month": "Jan", "Day": "30"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Transthyretin Amyloid Fibril Disrupting Activities of Extracts and Fractions from <i>Juglans mandshurica</i> Maxim. var. <i>cordiformis</i> (Makino) Kitam.", "Abstract": {"AbstractText": ["Transthyretin-related amyloidosis is a slowly progressive disorder caused by deposition of insoluble amyloid plaques formed by fibrillization of mutant or defective transthyretin (TTR) monomers that leads to neurodegeneration and organ failure. Thus, any compound exhibiting TTR amyloid formation inhibitory activity or TTR amyloid fibril disrupting activity might be a potential candidate for the development of therapies for these disorders. Our aim in this study was the evaluation of the TTR amyloid fibril disrupting potential of extracts of leaves and immature fruits of two <i>Juglans</i> plants, i.e., <i>Juglans mandshurica</i> var. <i>sachalinensis</i> and <i>Juglans mandshurica</i> var. <i>cordiformis</i>. The TTR amyloid fibril disrupting activity was measured by Thioflavin-T (ThT) assay and PROTEOSTAT<sup>\u00ae</sup> Protein aggregation assay methods. A fifty percent acetone extract of the fruits of <i>Juglans mandshurica</i> var. <i>cordiformis</i> showed strong amyloid fibril disrupting activity, and was further fractionated using different solvents. Ethyl acetate and <i>n</i>-butanol fractions showed significant activity in both assays. Syringic acid was isolated and identified as main compound in both of these fractions; however, it did not show any activity. Furthermore, some of the previously reported compounds from <i>Juglans</i> plants including naphthoquinone derivatives and phenolic compounds were evaluated to identify the potential bioactive compounds. Among them, juglone, a naphthoquinone derivative showed promising activity. However, juglone also showed strong cytotoxicity in HEK293 cells. Thus, future studies should focus on the isolation and identification of naphthoquinone derivatives or other compounds from <i>Juglans</i> plan ts with potent bioactivity and low cytotoxicity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. nirajchaudharypu@gmail.com."}, {"Identifier": [], "Affiliation": "Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, Kumamoto University, Kumamoto 862-0973, Japan. nirajchaudharypu@gmail.com."}], "LastName": "Chaudhary", "ForeName": "Niraj", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. 188y1008@st.kumamoto-u.ac.jp."}], "LastName": "Sasaki", "ForeName": "Ryoko", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. tshuto@gpo.kumamoto-u.ac.jp."}], "LastName": "Shuto", "ForeName": "Tsuyoshi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Botany, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan. wata-m@gpo.kumamoto-u.ac.jp."}], "LastName": "Watanabe", "ForeName": "Masato", "Initials": "M"}, {"Identifier": ["0000-0001-5140-4724"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Useful and Unique Natural Products for Drug Discovery and Development (UpRoD), Program for Building Regional Innovation Ecosystems at Kumamoto University, Kumamoto 862-0973, Japan. teppei@kumamoto-u.ac.jp."}], "LastName": "Kawahara", "ForeName": "Teppei", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. mann@gpo.kumamoto-u.ac.jp."}], "LastName": "Suico", "ForeName": "Mary Ann", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. tyokoya3@pha.u-toyama.ac.jp."}], "LastName": "Yokoyama", "ForeName": "Takeshi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. mineyuki@pha.u-toyama.ac.jp."}], "LastName": "Mizuguchi", "ForeName": "Mineyuki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. hirokai@gpo.kumamoto-u.ac.jp."}], "LastName": "Kai", "ForeName": "Hirofumi", "Initials": "H"}, {"Identifier": ["0000-0002-0509-1621"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, Kumamoto University, Kumamoto 862-0973, Japan. devkotah@kumamoto-u.ac.jp."}, {"Identifier": [], "Affiliation": "Department of Medicinal Botany, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan. devkotah@kumamoto-u.ac.jp."}], "LastName": "Devkota", "ForeName": "Hari Prasad", "Initials": "HP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Prealbumin"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Aggregates"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Amyloid"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Juglans"}, {"QualifierName": [], "DescriptorName": "Liquid-Liquid Extraction"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Leaves"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prealbumin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Aggregates"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Protein Aggregation, Pathological"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Da Costa G., Ribeiro-Silva C., Ribeiro R., Gilberto S., Gomes R.A., Ferreira A., Mateus \u00c9., Barroso E., Coelho A.V., Freire A.P., et al. Transthyretin amyloidosis: Chaperone concentration changes and increased proteolysis in the pathway to disease. PLoS ONE. 2015;10:e0125392. doi: 10.1371/journal.pone.0125392.", "ArticleIdList": ["10.1371/journal.pone.0125392", "PMC4492746", "26147092"]}, {"Citation": "Quintas A., Vaz D.C., Cardoso I., Saraiva M.J.M., Brito R.M.M. Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants. J. Biol. Chem. 2001;276:27207\u201327213. doi: 10.1074/jbc.M101024200.", "ArticleIdList": ["10.1074/jbc.M101024200", "11306576"]}, {"Citation": "Chan G.G., Koch C.M., Connors L.H. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis. J. Proteome Res. 2017;16:1659\u20131668. doi: 10.1021/acs.jproteome.6b00998.", "ArticleIdList": ["10.1021/acs.jproteome.6b00998", "28196416"]}, {"Citation": "Green N.S., Foss T.R., Kelly J.W. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc. Natl. Acad. Sci. USA. 2005;102:14545\u201314550. doi: 10.1073/pnas.0501609102.", "ArticleIdList": ["10.1073/pnas.0501609102", "PMC1253540", "16195386"]}, {"Citation": "Ando Y., Coelho T., Berk J.L., Cruz M.W., Ericzon B.G., Ikeda S.I., Lewis W.D., Obici L., Plant\u00e9-Bordeneuve V., Rapezzi C., et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J. Rare Dis. 2013;8:31. doi: 10.1186/1750-1172-8-31.", "ArticleIdList": ["10.1186/1750-1172-8-31", "PMC3584981", "23425518"]}, {"Citation": "Sekijima Y. Recent progress in the understanding and treatment of transthyretin amyloidosis. J. Clin. Pharm. Ther. 2014;39:225\u2013233. doi: 10.1111/jcpt.12145.", "ArticleIdList": ["10.1111/jcpt.12145", "24749898"]}, {"Citation": "Benson M.D., Waddington-Cruz M., Berk J.L., Polydefkis M., Dyck P.J., Wang A.K., Plant\u00e9-Bordeneuve V., Barroso F.A., Merlini G., Obici L., et al. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. N. Engl. J. Med. 2018;379:22\u201331. doi: 10.1056/NEJMoa1716793.", "ArticleIdList": ["10.1056/NEJMoa1716793", "29972757"]}, {"Citation": "Adams D., Gonzalez-Duarte A., O\u2019Riordan W.D., Yang C.-C., Ueda M., Kristen A.V., Tournev I., Schmidt H.H., Coelho T., Berk J.L., et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N. Engl. J. Med. 2018;379:11\u201321. doi: 10.1056/NEJMoa1716153.", "ArticleIdList": ["10.1056/NEJMoa1716153", "29972753"]}, {"Citation": "Coelho T., Maia L.F., Da Silva A.M., Cruz M.W., Plant\u00e9-Bordeneuve V., Suhr O.B., Concei\u00e7ao I., Schmidt H.H.J., Trigo P., Kelly J.W., et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J. Neurol. 2013;260:2802\u20132814. doi: 10.1007/s00415-013-7051-7.", "ArticleIdList": ["10.1007/s00415-013-7051-7", "PMC3825212", "23974642"]}, {"Citation": "Adams D., Buades J., Suhr O., Obici L., Coelho T. Preliminary assessment of neuropathy progression in patients with hereditary ATTR amyloidosis after orthotopic liver transplantation (OLT) Orphanet J. Rare Dis. 2015;10:P19. doi: 10.1186/1750-1172-10-S1-P19.", "ArticleIdList": ["10.1186/1750-1172-10-S1-P19"]}, {"Citation": "Guo L., Giasson B.I., Glavis-Bloom A., Brewer M.D., Shorter J., Gitler A.D., Yang X. A cellular system that degrades misfolded proteins and protects against neurodegeneration. Mol. Cell. 2014;55:15\u201330. doi: 10.1016/j.molcel.2014.04.030.", "ArticleIdList": ["10.1016/j.molcel.2014.04.030", "PMC4445634", "24882209"]}, {"Citation": "Savelieff M.G., Detoma A.S., Derrick J.S., Lim M.H. The ongoing search for small molecules to study metal-Associated amyloid-\u03b2 species in alzheimers disease. Acc. Chem. Res. 2014;47:2475\u20132482. doi: 10.1021/ar500152x.", "ArticleIdList": ["10.1021/ar500152x", "25080056"]}, {"Citation": "Korshavn K.J., Jang M., Kwak Y.J., Kochi A., Vertuani S., Bhunia A., Manfredini S., Ramamoorthy A., Lim M.H. Reactivity of Metal-Free and Metal-Associated Amyloid-\u03b2 with Glycosylated Polyphenols and Their Esterified Derivatives. Sci. Rep. 2015;5:17842. doi: 10.1038/srep17842.", "ArticleIdList": ["10.1038/srep17842", "PMC4674742", "26657338"]}, {"Citation": "Okada M., Mitsuhashi H., Wada H., Terabayashi S., Kondo K., Murata J., Kikuchi G. Newly Revised Illustrated Medicinal Plants of World. Hokuryukan Co., Ltd.; Tokyo, Japan: 2002. p. 612."}, {"Citation": "Zhou Y., Yang B., Jiang Y., Liu Z., Liu Y., Wang X., Kuang H. Studies on cytotoxic activity against HepG-2 cells of naphthoquinones from green walnut husks of Juglans mandshurica maxim. Molecules. 2015;20:15572\u201315588. doi: 10.3390/molecules200915572.", "ArticleIdList": ["10.3390/molecules200915572", "PMC6331885", "26343618"]}, {"Citation": "Xu H.L., Yu X.F., Qu S.C., Zhang R., Qu X.R., Chen Y.P., Ma X.Y., Sui D.Y. Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway. Eur. J. Pharmacol. 2010;645:14\u201322. doi: 10.1016/j.ejphar.2010.06.072.", "ArticleIdList": ["10.1016/j.ejphar.2010.06.072", "20655907"]}, {"Citation": "Chauhan N., Wang K.C., Wegiel J., Malik M.N. Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Curr. Alzheimer Res. 2004;1:183\u2013188. doi: 10.2174/1567205043332144.", "ArticleIdList": ["10.2174/1567205043332144", "15975066"]}, {"Citation": "Muthaiyah B., Essa M.M., Lee M., Chauhan V., Kaur K., Chauhan A. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2014;42:1397\u20131405. doi: 10.3233/JAD-140675.", "ArticleIdList": ["10.3233/JAD-140675", "25024344"]}, {"Citation": "Guo R., Cheng Z., Huang X., Song S. Research review in the main chemical constituents and pharmacological effects of Juglans mandshurica Maxim. Asian J. Tradit. Med. 2017;12:183\u2013200."}, {"Citation": "Babula P., Adam V., Havel L., Kizek R. Noteworthy Secondary Metabolites Naphthoquinones\u2014Their Occurrence, Pharmacological Properties and Analysis. Curr. Pharm. Anal. 2009;5:47\u201368. doi: 10.2174/157341209787314936.", "ArticleIdList": ["10.2174/157341209787314936"]}, {"Citation": "Fang L., Ren D., Cui L., Liu C., Wang J., Liu W., Min W., Liu J. Antifatigue, Antioxidant and Immunoregulatory Effects of Peptides Hydrolyzed from Manchurian Walnut (Juglans mandshurica Maxim.) on Mice. Grain Oil Sci. Technol. 2018;1:44\u201352."}, {"Citation": "Selamoglu Z. Polyphenolic compounds in human health with pharmacological properties. J. Tradit. Med. Clin. Natur. 2017;6:e137. doi: 10.4172/2573-4555.1000e138.", "ArticleIdList": ["10.4172/2573-4555.1000e138"]}, {"Citation": "Hu F.B., Stampfer M.J., Manson J.E., Rimm E.B., Colditz G.A., Rosner B.A., Speizer F.E., Hennekens C.H., Willett W.C. Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study. BMJ. 1998;317:1341\u20131345. doi: 10.1136/bmj.317.7169.1341.", "ArticleIdList": ["10.1136/bmj.317.7169.1341", "PMC28714", "9812929"]}, {"Citation": "Liao C.R., Kuo Y.H., Ho Y.L., Wang C.Y., Yang C.S., Lin C.W., Chang Y.S. Studies on cytotoxic constituents from the leaves of elaeagnus oldhamii maxim. In non-small cell lung cancer A549 cells. Molecules. 2014;19:9515\u20139534. doi: 10.3390/molecules19079515.", "ArticleIdList": ["10.3390/molecules19079515", "PMC6271351", "25000464"]}, {"Citation": "Colaric M., Veberic R., Solar A., Hudina M., Stampar F. Phenolic acids, syringaldehyde, and juglone in fruits of different cultivars of Juglans regia L. J. Agric. Food Chem. 2005;53:6390\u20136396. doi: 10.1021/jf050721n.", "ArticleIdList": ["10.1021/jf050721n", "16076123"]}, {"Citation": "Shi A., Huang J.-W., Liu Y., Yuan K. Separation, antioxidant and antimicrobial activities of chemical constituents from exocarp of Juglans mandshurica Maxim. Asian J. Chem. 2013;25:3361. doi: 10.14233/ajchem.2013.13725.", "ArticleIdList": ["10.14233/ajchem.2013.13725"]}, {"Citation": "Sekijima Y., Kelly J.W., Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des. 2008;14:3219\u20133230. doi: 10.2174/138161208786404155.", "ArticleIdList": ["10.2174/138161208786404155", "19075702"]}, {"Citation": "Connors L.H., Richardson A.M., Theberge R., Costello C.E. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid. 2000;7:54\u201369. doi: 10.3109/13506120009146826.", "ArticleIdList": ["10.3109/13506120009146826", "10842707"]}, {"Citation": "Westermark P., Sletten K., Johansson B., Cornwell G.G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA. 1990;87:2843\u20132845. doi: 10.1073/pnas.87.7.2843.", "ArticleIdList": ["10.1073/pnas.87.7.2843", "PMC53787", "2320592"]}, {"Citation": "Cornwell G.G., Murdoch W.L., Kyle R.A., Westermark P., Pitk\u00e4nen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am. J. Med. 1983;75:618\u2013623. doi: 10.1016/0002-9343(83)90443-6.", "ArticleIdList": ["10.1016/0002-9343(83)90443-6", "6624768"]}, {"Citation": "Ingbar S.H. Observations concerning the binding of thyroid hormones by human serum prealbumin. J. Clin. Investig. 1963;42:143\u2013160. doi: 10.1172/JCI104701.", "ArticleIdList": ["10.1172/JCI104701", "PMC289263", "13956488"]}, {"Citation": "Auf\u2019mkolk M., Koehrle J., Hesch R.D., Ingbar S.H., Cody V. Crystal structure of phlorizin and the iodothyronine deiodinase inhibitory activity of phloretin analogues. Biochem. Pharmacol. 1986;35:2221\u20132227. doi: 10.1016/0006-2952(86)90595-2.", "ArticleIdList": ["10.1016/0006-2952(86)90595-2", "3729977"]}, {"Citation": "Smith T.J., Davis F.B., Deziel M.R., Davis P.J., Ramsden D.B., Schoenl M. Retinoic acid inhibition of thyroxine binding to human transthyretin. BBA Gen. Subj. 1994;1199:76\u201380. doi: 10.1016/0304-4165(94)90099-X.", "ArticleIdList": ["10.1016/0304-4165(94)90099-X", "8280758"]}, {"Citation": "Zanotti G., D\u2019acunto M.R., Malpeli G., Folli C., Berni R. Crystal Structure of the Transthyretin\u2013Retinoic-Acid Complex. Eur. J. Biochem. 1995;234:563\u2013569. doi: 10.1111/j.1432-1033.1995.563_b.x.", "ArticleIdList": ["10.1111/j.1432-1033.1995.563_b.x", "8536704"]}, {"Citation": "Miroy G.J., Lai Z., Lashuel H.A., Peterson S.A., Strang C., Kelly J.W. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl. Acad. Sci. USA. 1996;93:15051\u201315056. doi: 10.1073/pnas.93.26.15051.", "ArticleIdList": ["10.1073/pnas.93.26.15051", "PMC26354", "8986762"]}, {"Citation": "Maia F., Almeida M.D.R., Gales L., Kijjoa A., Pinto M.M.M., Saraiva M.J., Damas A.M. The binding of xanthone derivatives to transthyretin. Biochem. Pharmacol. 2005;70:1861\u20131869. doi: 10.1016/j.bcp.2005.09.012.", "ArticleIdList": ["10.1016/j.bcp.2005.09.012", "16236271"]}, {"Citation": "Pullakhandam R., Srinivas P.N.B.S., Nair M.K., Reddy G.B. Binding and stabilization of transthyretin by curcumin. Arch. Biochem. Biophys. 2009;485:115\u2013119. doi: 10.1016/j.abb.2009.02.013.", "ArticleIdList": ["10.1016/j.abb.2009.02.013", "19268650"]}, {"Citation": "Cardoso I. Doxycycline disrupts transthyretin amyloid: Evidence from studies in a FAP transgenic mice model. FASEB J. 2006;20:234\u2013239. doi: 10.1096/fj.05-4509com.", "ArticleIdList": ["10.1096/fj.05-4509com", "16449795"]}, {"Citation": "Yokoyama T., Mizuguchi M. Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds. Biol. Pharm. Bull. 2018;41:979\u2013984. doi: 10.1248/bpb.b18-00166.", "ArticleIdList": ["10.1248/bpb.b18-00166", "29962408"]}, {"Citation": "Ercisli S., Esitken A., Turkkal C., Orhan E. The allelopathic effects of juglone and walnut leaf extracts on yield, growth, chemical and PNE compositions of strawberry cv. Fern. Plant Soil Environ. 2005;51:283\u2013287. doi: 10.17221/3587-PSE.", "ArticleIdList": ["10.17221/3587-PSE"]}, {"Citation": "Ercisli S., Turkkal C. Allelopathic effects of juglone and walnut leaf extracts on growth, fruit yield and plant tissue composition in strawberry cvs. \u201cCamarosa\u201d and \u201cSweet Charlie.\u201d J. Hortic. Sci. Biotechnol. 2005;80:39\u201342. doi: 10.1080/14620316.2005.11511888.", "ArticleIdList": ["10.1080/14620316.2005.11511888"]}, {"Citation": "Rietveld W.J. Allelopathic effects of juglone on germination and growth of several herbaceous and woody species. J. Chem. Ecol. 1983;9:295\u2013308. doi: 10.1007/BF00988047.", "ArticleIdList": ["10.1007/BF00988047", "24407348"]}, {"Citation": "Kiran Aithal B., Sunil Kumar M.R., Nageshwar Rao B., Udupa N., Satish Rao B.S. Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell Biol. Int. 2009;33:1039\u20131049. doi: 10.1016/j.cellbi.2009.06.018.", "ArticleIdList": ["10.1016/j.cellbi.2009.06.018", "19555768"]}, {"Citation": "Inbaraj J.J., Chignell C.F. Cytotoxic Action of Juglone and Plumbagin: A Mechanistic Study Using HaCaT Keratinocytes. Chem. Res. Toxicol. 2004;17:55\u201362. doi: 10.1021/tx034132s.", "ArticleIdList": ["10.1021/tx034132s", "14727919"]}, {"Citation": "Ji Y.B., Qu Z.Y., Zou X. Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp. Toxicol. Pathol. 2011;63:69\u201378. doi: 10.1016/j.etp.2009.09.010.", "ArticleIdList": ["10.1016/j.etp.2009.09.010", "19815401"]}, {"Citation": "Montenegro R.C., Ara\u00fajo A.J., Molina M.T., Filho J.D.B.M., Rocha D.D., Lop\u00e9z-Montero E., Goulart M.O.F., Bento E.S., Alves A.P.N.N., Pessoa C., et al. Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative. Chem. Biol. Interact. 2010;184:439\u2013448. doi: 10.1016/j.cbi.2010.01.041.", "ArticleIdList": ["10.1016/j.cbi.2010.01.041", "20138029"]}, {"Citation": "Barathi S., Shailima Vardhini R.D., Chitra P., Indra Arulselvi P. Cytotoxic effect of juglone on human peripheral blood lymphocytes. Asian J. Pharm. Clin. Res. 2013;6:178\u2013186."}, {"Citation": "Devkota H.P., Joshi K.R., Malla K.J., Watanabe T., Yahara S. Phenolic Compounds from the Leaves and Twigs of Heynea trijuga. Shoyakugaku Zasshi (Jpn. J. Pharmacogn.) 2014;68:97\u201398."}, {"Citation": "Devkota H.P., Adhikari B., Watanabe T., Yahara S. Nonvolatile Chemical Constituents from the Leaves of Ligusticopsis wallichiana (DC.) Pimenov & Kljuykov and Their Free Radical-Scavenging Activity. J. Anal. Methods Chem. 2018;2018:1794650.", "ArticleIdList": ["PMC5816836", "29484213"]}, {"Citation": "Miyata M., Sato T., Mizuguchi M., Nakamura T., Ikemizu S., Nabeshima Y., Susuki S., Suwa Y., Morioka H., Ando Y., et al. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding. Biochemistry. 2010;49:114\u2013123. doi: 10.1021/bi901677z.", "ArticleIdList": ["10.1021/bi901677z", "19950966"]}, {"Citation": "Miyata M., Sato T., Kugimiya M., Sho M., Nakamura T., Ikemizu S., Chirifu M., Mizuguchi M., Nabeshima Y., Suwa Y. The crystal structure of the green tea polyphenol (\u2212)-epigallocatechin gallate\u2014Transthyretin complex reveals a novel binding site distinct from the thyroxine binding site. Biochemistry. 2010;49:6104\u20136114. doi: 10.1021/bi1004409.", "ArticleIdList": ["10.1021/bi1004409", "20565072"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "21"}, {"Year": "2019", "Month": "1", "Day": "25"}, {"Year": "2019", "Month": "1", "Day": "29"}, {"Year": "2019", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["30704121", "PMC6384717", "10.3390/molecules24030500", "molecules24030500"]}}]}